Healthy Resources
Featured Centers
- Eating Out? Cut Calories, Heartburn
- 5 Good Ways to Save Money on Medicine
- 8 Ways to Treat Your Allergies
Autoplex® T (anti-inhibitor coagulant complex, heat treated)
Anti-Inhibitor Coagulant Complex Heat Treated
Caution: This product is to be used only in patients with inhibitors to Factor VIII.
Warning: This is a potent drug with potential hazards. For maximal safety and efficacy, carefully read and follow directions below.
Autoplex® T*, Anti-Inhibitor Coagulant Complex, Heat Treated, is a sterile product prepared from pooled human plasma with subsequent alcohol fractionation to Cohn Fraction IV1. It contains, in concentrated form, variable amounts of activated and precursor vitamin K-dependent clotting factors. Factors of the kinin generating system are also present. The product is standardized by its ability to correct the clotting time of Factor VIII deficient plasma or Factor VIII deficient plasma which contains inhibitors to Factor VIII.
When reconstituted, this product contains a maximum of 2 units per mL of heparin and a residual amount of polyethylene glycol (2 mg per mL, maximum). It also contains 0.02 M sodium citrate and the sodium content is 177 ± 15 milliequivalents per liter.
Laboratory testing of several lots of Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, has shown the presence of Factor VIII coagulant antigen (VIII:CAg). Although anamnestic response to this antigen following administration of the product was not observed during the clinical trials, the possibility of such a response does exist.
Each lot of Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, is assayed and labeled for units of Hyland Factor VIII correctional activity. Factor VIII correctional activity may not be exclusively related to the efficacious component(s). (See CLINICAL PHARMACOLOGY.)
During the manufacturing process, this product was heated for 6 days at 60°C. This heating step is designed to reduce the risk of transmission of hepatitis and other viral diseases. However, no procedure has been shown to be totally effective in removing hepatitis infectivity from Anti-Inhibitor Coagulant Complex.
Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, must be administered intravenously.
Anti-inhibitor coagulant complex is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although anti-inhibitor coagulant complex is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using anti-inhibitor coagulant complex.
Some viruses, such as parovovirus B19 and hepatitis A, may be more difficult to identify...
Read All Potential Side Effects and See Pictures of Autoplex-T »
Consult your...
*This product and/or its manufacture covered by U.S. Patent Nos. 4,286,056, 4,287,180, 4,357,321, 4,382,083, 4,459,288, and 4,495,278. The “T” indicates that the product is heat treated.
Anti-inhibitor coagulant complex is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although anti-inhibitor coagulant complex is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using anti-inhibitor coagulant complex.
Some viruses, such as parovovirus B19 and hepatitis A, may be more difficult to identify...
Read All Potential Side Effects and See Pictures of Autoplex-T »
Consult your...
Last reviewed on RxList: 1/13/2009
This monograph has been modified to include the generic and brand name in many instances.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.